J.B. Chemicals reported FY26 standalone net profit of ₹67.41 Cr, up 8.6% YoY, with revenue growth of 4.5% to ₹3,889.89 Cr.
Board recommended a final dividend of ₹9.30 per share and disclosed progress on merger with Torrent Pharma approved by shareholders.
Exceptional items of ₹27.18 Cr included severance costs and increased gratuity liability from New Labour Code implementation.
Auditors issued unmodified opinions on both standalone and consolidated financial results for the year ended March 31, 2026.